Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Billionaire Jim Simons’ Top Holdings: Inc. (AMZN), Colgate-Palmolive Company and More

Renaissance Technologies, founded by billionaire Jim Simons, has filed its latest 13F with the U.S. Securities and Exchange Commission disclosing its holdings as of the end of the first quarter of 2015. Jim Simons was one of the top-earning hedge fund managers in 2014, raking in $1.1 billion, according to Forbes. Renaissance Technologies is known for its high frequency strategies but it also has a long-term oriented investment strategy that has a pretty impressive track record. The fund revealed a total of 3,133 position in its latest 13F. The portfolio is valued at about $47 billion, up from $41.4 billion in the previous quarter. Renaissance Technologies started more than 620 new positions in the quarter, while it cut stakes in over 400 companies. Top holdings, in terms of value, of the fund include Colgate-Palmolive Company (NYSE:CL), Novo Nordisk A/S (ADR)(NYSE:NVO), Alaska Air Group Inc. (NYSE:ALK), and Inc. (NASDAQ:AMZN).


We track hedge funds to identify their best ideas. Our research revealed that imitating hedge funds’ top ideas has historically managed to generate alpha even though the filings are delayed up to a maximum of 45 days. As part of our backtesting, we used a 60-day delay to be on the conservative side, and our research showed that the 15 most popular small-cap stocks among hedge funds still outperformed the S&P 500 Total Return Index by an average of 95 basis points per month between 1999 and 2012. After adjusting for risk, our calculations revealed that these stocks’ monthly alpha was 80 basis points. We have been sharing and tracking the performance of these stocks since the end of August 2012 and they have returned 143% over the last 32.5 months, outperforming the S&P 500 ETF by over 80 percentage points (see more details here).

We also spared some time and analyzed the historical performance of RenTech’s stock picks. The funds’ most picks are very short-term oriented and paying attention to them is a waste of time. However, its top positions performed much better than index funds. The funds’ top picks have, usually, a lower risk profile than the rest of the market. Between 1999 and 2012, the top 5 stock positions in RenTech’s 13F portfolio actually beat the S&P 500 Total Return Index by more than 3 percentage points per year.  Three percentage points may not sound a lot but you have to keep in mind that these stocks have lower risk profile and perform much better during rough periods. For instance, imitating Jim Simons’ top 5 stock holdings would have returned an average of 1.17% per month between 2008 and 2012 and outperformed the S&P 500 Total Return Index by more than 10 percentage points per year. Most fund managers fail to beat the market and investors have been switching to low cost index funds as a result of that. Our research shows that investors would have been better off by simply imitating RenTech’s top 5 picks. Now let’s take a closer look at these stocks.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.